Eric Sheu

Title: Eric Sheu: Innovator in Oral Drug Delivery Systems

Introduction

Eric Sheu is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of orally disintegrating dosage forms. His work focuses on enhancing the delivery and absorption of active pharmaceutical ingredients.

Latest Patents

Eric Sheu holds a patent for an "Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and use." This innovative formulation is designed for the oral administration of avanafil, a Type V phosphodiesterase inhibitor. The orally disintegrating tablets (ODTs) rapidly dissolve in the oral cavity, facilitating improved absorption of the active agent in the duodenum. The invention also includes methods for selecting components that enhance absorption and optimize the physical properties of the dosage forms.

Career Highlights

Eric Sheu is currently associated with Vivus, Inc., where he continues to advance his research in drug delivery systems. His expertise in formulating effective pharmaceutical products has positioned him as a key player in the industry.

Collaborations

Eric collaborates with Calvin Theodore Broman, contributing to the innovative projects at Vivus, Inc. Their combined efforts aim to push the boundaries of pharmaceutical technology.

Conclusion

Eric Sheu's work in developing orally disintegrating dosage forms represents a significant advancement in the field of drug delivery. His innovative approach enhances the effectiveness of medications, ultimately benefiting patients who rely on these treatments.